Skip to content
Best Biochem | Custom Peptide | Protein | Antibody | RNA oligos | Inhibitor Logo
  • About us
    • Home
  • About us
    • Home

Kisspeptin-10 (Kp-10), Metastin (45-54)

Home/Catalog peptide/Kisspeptin-10 (Kp-10), Metastin (45-54)
Kisspeptin-10 (Kp-10), Metastin (45-54)Admin2021-01-06T06:06:35+00:00
Product Name Kisspeptin-10 (Kp-10), Metastin (45-54)
Purity HPLC>95%
Description This peptide sequence is found in residues 45 to 54 of Metastin (also referred to as Kisspeptin-10). This peptide increases plasma concentrations of GH (Growth Hormone) and LH (Luteinizing Hormone) in prepubertal dairy heifers. This peptide is the minimal sequence needed to activate GPR54 signaling, which may function in negatively regulating CXCR4’s role in programming tumor metastasis. Specifically, Kisspeptin-10 inhibits signaling and chemotaxis induced by SDF-1.
Storage -20°C
References Kadokawa, H. et al. J. Endocrinol. 196, 331 (2008); Kotani, M. et al. J. Biol. Chem. 276, 34631 (2001); Navenot, J.M. et al. Cancer Res, 65, 10450 (2005).
Molecular Weight 1302.5
Sequence (One-Letter Code) YNWNSFGLRF-NH2
Sequence (Three-Letter Code) H - Tyr - Asn - Trp - Asn - Ser - Phe - Gly - Leu - Arg - Phe - NH2

Other Products

  • Research peptides
  • Antibodies
  • Drug for research
  • Inhibitor and agonist

Related Products

Beta-Amyloid (1-42), Human

Beta-Amyloid (1-42), FAM-labeled, Human

Amylin (1-37), rat, mouse

Amylin (1-37), human, amide

rCRAMP

LL-37 Citrulline

β-Defensin 2 (human)

Contact us
  • Skype: elisa.qiujx
  • [email protected]
  • WeChat

  • QQ: 1652852700

CUSTOM SERVICES

  • Peptide Synthesis
  • Antibody Production
  • DNA/RNA Synthesis

CHARACTERISTIC PRODUCTS

  • Research Peptide
  • Antibody
  • API and Impurity
  • Inhibitor and Agonist

Contact Info

No. 199 Huayuan Dong Road, Wuzhong Qu,Suzhou Shi, Jiangsu Sheng, China

Phone: +86 18021243762 (same as Wechat)

Email: [email protected]

Web: bestbiochem.com

Recent Tweets

Copyright 2012 - 2017 BestBiochem | All Rights Reserved
LinkedInFacebookTwitter
Go to Top